Report ID: SQMIG35I2290
Report ID:
SQMIG35I2290 |
Region:
Global |
Published Date: July, 2001
Pages:
157
|
Tables:
63 |
Figures:
75
North America is predicted to have the greatest market share due to considerable R&D in the medical industry. The business is booming as researchers work to find a treatment for HIV. Because of China's enormous manufacturing base, Asia Pacific is expected to develop significantly. The use of n-acetylcysteine for paracetamol intoxication is predicted to drive a significant increase in Europe. Eastern and southern Africa will account for over 52% of all HIV-infected persons by 2020. Because of the growing number of HIV patients, Latin America, the Middle East, and Africa will experience a significant increase by the end of the projection period.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONN-Acetylcysteine Market size was valued at USD 1083.78 million in 2019 and is poised to grow from USD 1316.79 million in 2023 to USD 7598.08 million by 2031, growing at a CAGR of 21.5% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2290